Xingqi Eye Medicine: Net profit in 2025 was 696 million yuan, a year-on-year increase of 105.84%.

Xingqi Eye Drops announced that the company has released a summary of its 2025 annual report, achieving operating income of 2.473 billion yuan, a year-on-year increase of 27.24%; net profit attributable to shareholders of the listed company was 696 million yuan, a year-on-year increase of 105.84%. The company plans to distribute a cash dividend of 10 yuan for every 10 shares to all shareholders, with a total of 246,429,527 shares as the base, and no bonus shares will be issued. Additionally, the company plans to allocate 4.5 bonus shares for every 10 shares using capital reserves. The company's net profit for Q4 was 970 million yuan, compared to 2.64 billion yuan in Q3, resulting in a 63% quarter-on-quarter decrease in net profit. Analysts had forecasted a consensus for Q4 net profit at 1.82 billion yuan, but the actual figure of 970 million yuan fell below expectations.